Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: A phase III randomized, double-blind, placebo-controlled trial
Victor Biton, Samuel F Berkovic, Bassel Abou-Khalil, Michael R Sperling, Martin E Johnson, Sarah Lu
Epilepsia | WILEY | Published : 2014
This study was sponsored by UCB Pharma. UCB Pharma was involved in the design and conduct of the study, and collection, management, and analysis of the data. The authors thank the members of the N01253 Study Group and the patients who participated in the study for their contribution to the research; Laurent Turet, PhD (UCB Pharma), for critical review and coordination of the manuscript preparation; and David Sen, PhD (UCB Pharma), for providing statistical input. Sally Cotterill, PhD (QXV Communications, Macclesfield, United Kingdom) provided writing support, which was funded by UCB Pharma.